Emergencies in the Cancer Patient 2026 — On Demand

The field of oncologic emergencies has evolved rapidly over the past 15+ years, advancing in parallel with the ongoing development of cancer treatments and interventions. While complications from traditional chemotherapies remain common, the rise of novel cancer treatments has introduced a broader and more complex spectrum of patient presentations—many of which are now increasingly encountered in emergency departments across the country. With few dedicated cancer-specific emergency rooms, these patients are often inappropriately triaged, misdiagnosed, under-treated, or redirected to their oncologists without adequate resolution of their urgent concerns.

Now in its eighth year, this course brings together specialists from across all areas of the cancer treatment spectrum to provide emergency department providers and staff with the knowledge and tools needed to effectively manage both common and uncommon oncologic emergencies. 

This course is designed for physicians, nurse practitioners, physician assistants, and registered nurses involved in the treatment and management of patients with active malignancies/cancers who present with acute complaints in an emergent room setting. We are pleased to offer flexible learning options, with the opportunity to participate live in person or virtually, or register for on demand access to the recorded program.

1. Identify and recognize the most common presenting complaints of cancer patients in emergency rooms.
2. Discuss current and developing cancer therapeutics with respect to their side-effects and complications.
3. Recognize the current limitations and challenges that remain in efficiently addressing cancer patient emergencies.

We are pleased to offer flexible learning options for this course. Participants may register for on demand access available after the live event or attend the live event in person or virtually. 

• Register for On Demand Access

• Register for Live Participation 

Registration Fees

• Early Rates (Available through October 2, 2026)

  • Physicians (MDs, PhDs, DOs): $500

  • Advanced Practice Providers: $400

  • Nurses and Other Healthcare Professionals: $350

  • Residents and Fellows: $150

  • Industry Professionals: Not applicable (general rates apply)*

  • MSK Employees: Complimentary**

• General Rates (After October 2, 2026)

  • Physicians (MDs, PhDs, DOs): $550

  • Advanced Practice Providers: $450

  • Nurses and Other Healthcare Professionals: $400

  • Residents and Fellows: $200

  • Industry Professionals: $965*

  • MSK Employees: Complimentary**

Discounted registration is available for select groups, including students, MSK alumni/affiliates, and participants from low- and lower-middle-income countries. View our Policy on Registration Discounts for more information. Additionally, we're pleased to offer a special discounted rate for CONCERN members. Please email [email protected] for further details.

Please note that the on demand program is non-refundable. For additional details, review our Cancellation Policy.

*An industry professional is defined as any individual, irrespective of their provider type (such as MDs, PhDs, APPs, RNs, etc.) that is employed by an ineligible company. Please review our Registration Policy for Industry Professionals information.
*MSK employees receive complimentary registration for all CME programs by signing in with MSK credentials (SSO).

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

This enduring material has been approved for:

• AMA PRA Category 1 Credit(s)™

• American Board of Internal Medicine (ABIM) MOC

MSK Course Director

George K. Wang, MD, PhD
Associate Attending, Emergency Care Service

MSK Course Planner 

Adam D. Klotz, MD
Chief, Emergency Care Service

A complete faculty list and schedule will be announced soon.

Mitigation of Relevant Financial Relationships

Memorial Sloan Kettering Cancer Center adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers, or others are required to disclose all financial relationships with ineligible companies (commercial interests). All relevant financial relationships have been mitigated prior to the commencement of the activity.